Moving ahead with the Stop TB Strategy: where are we today? Dr Mario Raviglione Director, WHO Stop TB Department Joint Meeting of Core Teams and High Burden.

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
What, Where, How and Action Steps… XDR-TB
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
Technical Advisory Group meeting, WHO/WPRO
Global Plan to Stop TB Stop TB Partnership
What, Where, How and Action Steps… XDR-TB
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
The Global Plan to Stop TB, (1)
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
World Health Organization
PUTTING AN END TO TB WHERE ARE THE OPPORTUNITIES AND WHAT ARE THE CHALLENGES? STRATEGY MEETING ON RESOURCE MOBILIZATION FOR THE GLOBAL FUND TO FIGHT AIDS,
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Challenges of Global Alcohol Policy Developments FIVS Public Policy Conference 7-9 April 2014 Brussels, Belgium.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
THE ROLE OF STOP TB GHANA PARTNERSHIP Chief Austin A. Obiefuna National Coordinator SECRETARIAT CO-HOSTED BY AFRO GLOBAL ALLIANCE (GH) & GHANA SOCIETY.
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps…
DOTS Expansion: Monitoring Drugs Leopold Blanc TBS, Stop TB WHO, Communicable Diseases.
IHP+: introduction and ministerial review Action for Global Health Conference Strengthening Accountability to Achieve the Health MDGs Madrid, 7 th June.
Evidence and Information for Policy Christopher J.L. Murray Executive Director Evidence and Information for Policy World Health Organization National Capacity.
Historical development ICC-TB recommends creating a Partnership in meeting, Sept 2004 WHO signed co-funding agreement with Federation Red Cross, Aug 2006.
Session 11: MDR & XDR-TB: How Can Business Help Stem the Tide?
World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Investing in Youth: Population, Health and Social Challenges UNFPA Mexico October 2004.
Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 2: BACKGROUND ON TUBERCULOSIS Insert country/ministry.
Proposed Post-2015 Global Tuberculosis Strategy and Targets Dr Mario Raviglione Director, Global TB Programme World Health Organization, Geneva, Switzerland.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
TB, MDR-TB and XDR-TB in South Africa October 2006.
The revised TB/HIV indicators and update on the process of harmonization Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group.
Strategic Information and the Control of Tuberculosis Brian Williams and Chris Dye TB programme, Monitoring and Evaluation, WHO.
WHO and International Panel International Collaborative Effort on Injury Statistics Hyatt Regency, Washington September 7-8, 2006.
Report of the 2nd ad hoc Committee on the TB epidemic Jaap F. Broekmans STOP TB Partner’s Forum NEW DELHI June 2004.
Country Office for Bangladesh Towards reaching the Millennium Development Goals Dr Erwin Cooreman Medical Officer (TB) WHO-Bangladesh.
Current Health Concerns: Tuberculosis Saharwash Jamali Hamna Jaffar.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
The Bank’s Regional HIV/AIDS Strategies An Overview.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
Advocacy, Communication and Social Mobilization Working Group ACSM Paul Sommerfeld, Chair.
Stop TB Partnership Coordinating Board meeting October 2004 Beijing The Second Global Plan to Stop TB:
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Global Tuberculosis Control 2007 Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
TB and the right to health Nelson Otwoma National Coordinator- NEPHAK.
World Health Organization
Palliative Care and M/XDR-TB Global burden of M/XDR-TB
financial requirements
reporting rate of discarded cases* per 100'000 population**
TUBERCULOSIS, TB/HIV & MDR-TB
اپيدميولوژي و كنترل سِل
PROGRESS IN GLOBAL TB CONTROL
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016
(70 countries or 36%) (23 countries or 12%)
Countries with Genotype data available
Vietnam Investment and Finance for TB
Countries having introduced HepB vaccine
Countries Using Mening Vaccine in National Immunization Schedule 2011
Onset of most recent case Number of infected districts
PROGRESS IN GLOBAL TB CONTROL
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
The STOP TB Strategy – 2009 VISION: A TB-free world
A Time of Commitments and Actions to accelerate action to End TB
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
Presentation transcript:

Moving ahead with the Stop TB Strategy: where are we today? Dr Mario Raviglione Director, WHO Stop TB Department Joint Meeting of Core Teams and High Burden Countries Paris, 30 October 2006

The burden of TB in million deaths in 2005 – 98% of these in developing world 219,000 deaths due to TB/HIV MDR-TB present in 102 of 109 countries and settings surveyed, XDR-TB emerging 8.9 million new cases in 2005 – 80% in 22 high- burden countries

Highest incidence rates per capita in Africa Highest numbers in Asia - Emergency in Europe = 300 or more The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved

Global TB control targets 2005: World Health Assembly: - To detect at least 70% of infectious TB cases - To treat successfully at least 85% of detected cases 2015: 50% reduction in TB prevalence and death rates by : Goal 6: Combat HIV/AIDS, malaria and other diseases Target 8: to have halted by 2015 and begun to reverse the incidence… Indicator 23: prevalence and deaths associated with TB Indicator 24: proportion of TB cases detected and cured under DOTS

Over 26 million patients treated under DOTS with high cure rates Case detection rate or cure rate (%) Target cure 85%Target detection 70%

Trends in global TB prevalence and deaths

Africa epidemic possibly peaking: Africa World E Europe World excluding AFR and EEUR Africa E. Europe World World (exc E.Europe & Africa) Global incidence flattening? Estimated TB incidence/100K/yr

XDR-TB: extensive drug-resistance TB XDR: MDR-TB plus resistance to any fluoroquinolone and, at least, 1 of 3 injectables (ami, kana or capreo) Of 17,690 isolates from 49 countries during % were MDR; 2% XDR XDR found in: USA: 4% of MDR Latvia: 19% of MDR S Korea: 15% of MDR XDR found in Southern Africa associated with HIV

1.New approach needed that built on DOTS, while mainstreaming responses to new threats, full partner engagement, service innovations and research 2.Wide consultation with NTPs and partners on components stakeholders interviewed on key messages of new approach Should reinforce "access to all" and "impact" implications Should recognize both "individual" and "public health" aims Further clarify how to work within systems, serve hard-to-reach and research roles 4.Approved by the WHO Strategic and Technical Advisory Group for TB (STAG-TB) 5.Endorsed by the Stop TB Working Groups and partners 6.Endorsed by Stop TB Partnership Coordinating Board Stop TB Strategy – Development

Vision: A WORLD FREE OF TB Goal: To dramatically reduce the global burden of TB by 2015 in line with the MDGs and the Stop TB Partnership targets Objectives: Achieve universal access to high-quality diagnosis and patient- centred treatment Reduce the human suffering and socio-economic burden associated with TB Protect poor and vulnerable populations from TB, TB/HIV and multidrug-resistant TB Support development of new tools and enable their timely and effective use Stop TB Strategy Vision, Goals, Objectives

Stop TB Strategy to reach the 2015 MDGs

In conclusion… New challenges require the new Stop TB Strategy The new Stop TB Strategy underpins and strengthens the Global Plan to Stop TB, The Strategy & The Plan...

Roll-out of the Strategy Global Plan to Stop TB, , January 2006 The Lancet and World TB Day, March 2006 Survey of HBCs for 2007 Global TB Control Report Planning and implementation support to countries ongoing WHO Stop TB Strategy document, June WHO Regional Stop TB plans based on Strategy; others in process

Some interim indicators on implementation of Stop TB Strategy components 1, 2, 3 WHO Questionnaire of 22 HBCs, 2006

Some interim indicators on implementation of Stop TB Strategy components 4, 5, 6 WHO Questionnaire of 22 HBCs, 2006

The highest priority is basic DOTS quality - –Where DOTS has been scaled up very fast –Where health systems, HRH and labs are very weak –Where HIV epidemic and MDR-TB problems are the most severe Catch 22 - Governments and partners with the least capacity often have the greatest need for new approaches. Implementing new approaches while building capacity demands new resources and partners Scaling up - We need to work in a new way – piloting, assessing & sharing results, while preparing and initiating scaling up. Sequential approaches won't work. Accountability – High demands from donors and civil society for documented results Key challenges

Country-led planning and immediate action with expanded range of partners High-level country-based advocacy for increased national budgets and human resources to respond, within overall sector plans High-level regional and global advocacy –Regional Ministerial Fora 2007 – Africa, Europe –Regional political bodies (RCs) and partnerships –Focus on Asia session at Stop TB CB, –Latin America Initiative by SE Sampaio, –G8 in Germany, –Key bilaterals, multilaterals, and world leaders engaged against poverty and HIV and for MDGs, HSS and R&D Next Steps